{
    "id": "c2a316b42a",
    "level": "sentence",
    "abstract": [],
    "body_text": [
        {
            "text": "The immune system constitutes one of the first-line defenses to prevent tumor development, owing to its ability to identify and destroy tumor cells. ",
            "section": "Introduction"
        },
        {
            "text": "This process, which has been termed cancer immunosurveillance, has gained considerable attention in the last years. ",
            "section": "Introduction"
        },
        {
            "text": "One of the most important immune effector cells are macrophages, which exert multiple biological roles, including antigen presentation as well as the regulation of inflammation and tissue remodeling. ",
            "section": "Introduction"
        },
        {
            "text": "Moreover, macrophages are involved in the etiology of a variety of pathological conditions including cancer. ",
            "section": "Introduction"
        },
        {
            "text": "In particular, tumor-associated macrophages (TAMs) have been found to contribute to tumor initiation, progression and metastasis. ",
            "section": "Introduction"
        },
        {
            "text": "TAMs have been proposed to exhibit many similarities in terms of gene expression and functions with \"alternativelyactivated\" M2 macrophages. ",
            "section": "Introduction"
        },
        {
            "text": "1 Macrophages are classified in two different polarization phenotypes according to distinct functional properties:",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "1"
                }
            ]
        },
        {
            "text": "The aRF locus is frequently inactivated in human cancer. ",
            "section": "Introduction"
        },
        {
            "text": "The oncosuppressor aRF has indeed been described as a general sensor for different situation of cellular stress. ",
            "section": "Introduction"
        },
        {
            "text": "We have previously demonstrated that aRF deficiency severely impairs inflammatory responses in vitro and in vivo, establishing a role for aRF in the regulation of innate immunity. ",
            "section": "Introduction"
        },
        {
            "text": "The aim of the present work was to get further insights into the immune functions of aRF and to evaluate its possible contribution to the polarization of macrophages toward the M1 or M2 phenotype. ",
            "section": "Introduction"
        },
        {
            "text": "Our results demonstrate that resting arf \u2212/\u2212 macrophages express high levels of Ym1 and Fizz-1, two typical markers of alternatively-activated macrophages (M2). ",
            "section": "Introduction"
        },
        {
            "text": "additionally, arf \u2212/\u2212 peritoneal macrophages showed an impaired response to lipopolysaccharide (a classical inducer of M1 polaryzation) and a reduced production of pro-inflammatory cytokines/chemokines. ",
            "section": "Introduction"
        },
        {
            "text": "Moreover, upon stimulation with interleukin-4 (IL-4), an inducer of the M2 phenotype, well established M2 markers such as Fizz-1, Ym1 and arginase-1 were upregulated in arf \u2212/\u2212 as compared with wild type macrophages. ",
            "section": "Introduction"
        },
        {
            "text": "accordingly, the cytokine and chemokine profile associated with the M2 phenotype was significantly overexpressed in arf \u2212/\u2212 macrophages responding to IL-4. ",
            "section": "Introduction"
        },
        {
            "text": "In addition, multiple pro-angiogenic factors such as VeGF and MMp-9 were also increased. ",
            "section": "Introduction"
        },
        {
            "text": "In summary, these results indicate that aRF contributes to the polarization and functional plasticity of macrophages.",
            "section": "Introduction"
        },
        {
            "text": "Abbreviations: ARF, alternative reading frame; Arg-1, arginase-1; COX-2, cyclooxigenase-2; Fizz-1, found in inflammatory zone 1;",
            "section": "Introduction"
        },
        {
            "text": "IFN\u03b3, interferon \u03b3; LPS, lipopolysaccharide; MMR, mannose receptor; MMP-9, matrix metalloproteinase-9; M1, classicallyactivated macrophages; M2, alternatively-activated macrophages; NO, nitric oxide; iNOS, inducible nitric oxide syntase; PGE 2 , prostaglandin E2; TAM, tumor-associated macrophages; TIMP-3, metalloproteinase inhibitor 3; TNF\u03b1, tumor necrosis factor \u03b1;",
            "section": "Introduction"
        },
        {
            "text": "VEGF, vascular endotelial growth factor; Ym1, chitinase 3-like 3",
            "section": "Introduction"
        },
        {
            "text": "classically-activated (M1) and alternatively-activated (M2) macrophages. ",
            "section": "Introduction"
        },
        {
            "text": "2 M1 macrophages are induced by interferon \u03b3 (IFN\u03b3) either alone or in combination with microbial stimuli such as lipopolysaccharide (LPS) or cytokines (e.g., tumor necrosis factor \u03b1, TNF\u03b1, and granulocyte macrophage colony-stimulating factor, GM-CSF). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "2"
                }
            ]
        },
        {
            "text": "These macrophages produce pro-inflammatory cytokines including TNF\u03b1, interleukin (IL)-1, IL-6, IL-12 or IL-23, as well as other pro-inflammatory mediators such as nitric oxide (NO, upon the expression of inducible nitric oxide synthase, iNOS), all of which are essential for killing pathogens and for priming antitumor immune responses. ",
            "section": "Introduction"
        },
        {
            "text": "2 In contrast, IL-4/IL-13 stimulation induces M2 macrophages, which have an important role in the response to parasites, tissue remodeling, angiogenesis and tumor progression. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "2"
                }
            ]
        },
        {
            "text": "M2 macrophages downregulate IL-12 expression and produce the anti-inflammatory cytokine IL-10. ",
            "section": "Introduction"
        },
        {
            "text": "Additionally, M2 macrophages are characterized by the expression of several surface markers including arginase 1 (Arg-1) and the mannose receptor (MMR). ",
            "section": "Introduction"
        },
        {
            "text": "[2][3][4] Our results demonstrate that ARF deficiency switch macrophages to a M2-like phenotype. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[2]"
                },
                {
                    "start": 3,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[3]"
                },
                {
                    "start": 6,
                    "end": 9,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[4]"
                }
            ]
        },
        {
            "text": "Thus, resting Arf \u2212/\u2212 macrophages overexpress typical M2 markers such as Ym1 and Fizz-1, as well as the Ccl17 chemokine. ",
            "section": "Introduction"
        },
        {
            "text": "Furthermore, compared to their wild type (WT) counterparts, ARF-deficient cells showed an altered expression of pro-inflammatory mediators and cytokines such as NO, IL-12, IL-6 and TNF\u03b1 after stimulation with LPS. ",
            "section": "Introduction"
        },
        {
            "text": "The cytokine/chemokine pattern induced by IL-4 stimulation appeared upregulated in macrophages isolated from Arf \u2212/\u2212 mice, showing a M2-like phenotype featuring higher levels of IL-10, Ccl22, Ccl5, Ccr3 or Ccr5. ",
            "section": "Introduction"
        },
        {
            "text": "A significantly enhanced arginase activity and the upregulation of surface receptors such as Fizz-1 and Ym1 were also observed. ",
            "section": "Introduction"
        },
        {
            "text": "Finally, important pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and",
            "section": "Introduction"
        },
        {
            "text": "Interestingly, genes associated with tissue remodelling such as found in inflammatory zone 1 (FIZZ1) and chitinase 3-like 3 (YM1) have been considered new M2-polarization associated genes. ",
            "section": "Introduction"
        },
        {
            "text": "5,6 We have recently described that the tumor suppressor ARF (alternative reading frame; p14 ARF in humans, p19 ARF in mice) plays an important role in the regulation of innate immunity and inflammatory processes. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "5,"
                },
                {
                    "start": 2,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "6"
                }
            ]
        },
        {
            "text": "7 Mice lacking the Arf gene are resistant to LPS-endotoxic shock, and Arf-deficient macrophages showed a severely impaired production of inflammatory mediators including NO, cytokines and chemokines. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "7"
                }
            ]
        },
        {
            "text": "Since this phenotype showed numerous similarities to that of M2 macrophages, we wondered whether ARF could contribute to the polarization and functional plasticity of macrophages. ",
            "section": "Introduction"
        },
        {
            "text": ". expression of M1 and M2 markers in resting WT and aRF-deficient macrophages. peritoneal WT and aRF-deficient macrophages were obtained as described in Material and Methods. cells were cultured in RpMI 1640 medium for 24 h, followed by RNa isolation. (A) Mannose macrophage receptor (MMR), arginase 1 (arg-1), Ym1 and Fizz-1 expression was assessed by quantitative pcR. Results were obtained from five independent experiments performed in triplicate and data are reported as means \u00b1 sD (B) iNOs, cOX-2, IL-6 and TNF\u03b1 expression was assessed by quantitative pcR. Results were obtained from five independent experiments performed by triplicate and data are reported as means \u00b1 sD (C) Quantitative pcR confirmation of selected genes identified by microarray studies. Results were obtained from three independent experiments with 4-5 mice per group and data are reported as means \u00b1 sD *p < 0.05 and **p < 0.01, as compared with WT macrophages.",
            "section": "Introduction"
        },
        {
            "text": "We next compared the genetic profiles of WT and Arf \u2212/\u2212 macrophages after stimulation with LPS. ",
            "section": "Introduction"
        },
        {
            "text": "We found that LPS induced 31 pro-inflammatory genes in WT macrophages including genes coding for chemokines (Ccl3, Ccl4, Cxcl1, and Cxcl10), cytokines (IL-1\u03b1, IL-1\u03b2) and other inflammatory mediators such as TNF\u03b1 and IFN\u03b3 ( Fig. 3A; Table 2). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 223,
                    "end": 239,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Fig. 3A; Table 2"
                }
            ]
        },
        {
            "text": "LPS-treated Arf \u2212/\u2212 cells expressed markedly lower levels of 22 out of these 31 genes, and a significant upregulation of 8 genes, including Ccl5 and Ccl17. ",
            "section": "Introduction"
        },
        {
            "text": "Additionally, we found two genes only upregulated in Arf \u2212/\u2212 macrophages responding to LPS, namely Ccl8 and IL10ra ( Fig. 3; Table 2).",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 117,
                    "end": 123,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Fig. 3"
                },
                {
                    "start": 125,
                    "end": 132,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "Table 2"
                }
            ]
        },
        {
            "text": "The absence of ARF promotes exacerbated M2 polarization in response to IL-4 and IL-3. ",
            "section": "Introduction"
        },
        {
            "text": "IL-4 and IL-13 are prototypic cytokines that induce the alternative activation of macrophages. ",
            "section": "Introduction"
        },
        {
            "text": "To ascertain the role of ARF in this pathway, we evaluated the M2-like response on WT and Arf \u2212/\u2212 peritoneal macrophages generated upon stimulation with IL-4 or IL-13. ",
            "section": "Introduction"
        },
        {
            "text": "As shown in Figure 4A, LPS or IFN\u03b3 treatment induced NO release, a marker for classical activation, whereas IL-4 or IL-13 did not affect the levels of this pro-inflammatory mediator. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 21,
                    "type": "figure",
                    "text": "Figure 4A"
                }
            ]
        },
        {
            "text": "Consistently with these findings, neither iNOS nor COX-2 overexpression was observed in macrophages activated with IL-4 or IL-13 ( Fig. 4C). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 131,
                    "end": 139,
                    "type": "figure",
                    "text": "Fig. 4C)"
                }
            ]
        },
        {
            "text": "Opposite to the NO release observed by M1-activated macrophages, the alternative polarization is characterized by the upregulation of Arg-1, an inducible enzyme that competes with iNOS for l-arginine and thus can prevent NO release. ",
            "section": "Introduction"
        },
        {
            "text": "8 Classical activation of macrophages with LPS had no effect on Arg-1 activation (Fig. 4D). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "8"
                },
                {
                    "start": 81,
                    "end": 90,
                    "type": "figure",
                    "text": "(Fig. 4D)"
                }
            ]
        },
        {
            "text": "In contrast, IL-4 promoted a > 50-fold induction in Arg-1 expression in WT macrophages (Fig. 4D). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 87,
                    "end": 96,
                    "type": "figure",
                    "text": "(Fig. 4D)"
                }
            ]
        },
        {
            "text": "Interestingly, Arf \u2212/\u2212 macrophages showed a much more striking and significant increase of Arg-1 after IL-4 stimulation (Fig. 4D). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 120,
                    "end": 129,
                    "type": "figure",
                    "text": "(Fig. 4D)"
                }
            ]
        },
        {
            "text": "The markedly raised mRNA levels for Arg-1 in Arf \u2212/\u2212 macrophages were confirmed at the protein level by immunoblotting analysis (Fig. 4E). ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 128,
                    "end": 137,
                    "type": "figure",
                    "text": "(Fig. 4E)"
                }
            ]
        },
        {
            "text": "Moreover, an increment in arginase matrix metalloproteinase 9 (MMP-9) were increased in ARFdeficient macrophages, suggesting that these cells may exert protumorigenic functions.",
            "section": "Introduction"
        },
        {
            "text": "In summary, the current study strongly suggests that ARF has a profound influence in regulating the polarization of macrophages and points to ARF as a novel regulator of the immune tumor microenvironment.",
            "section": "Introduction"
        },
        {
            "text": "To explore the contribution of the tumor suppressor ARF to macrophage polarization, we first analyzed by quantitative PCR the expression levels of typical hallmarks of M2 polarization on WT vs. Arf \u2212/\u2212 resting macrophages. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "The levels of the genes encoding Fizz-1 and Ym1 were significantly higher in ARFdeficient macrophages than in their WT counterparts. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "Arg-1 also showed a tendency to be overexpressed, although the data were not statistically significant. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "Nevertheless, MMR gene was unaffected in this situation (Fig. 1A). ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 56,
                    "end": 65,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "(Fig. 1A)"
                }
            ]
        },
        {
            "text": "In contrast, M1 polarization markers such as iNOS, COX-2, IL-6 or TNF\u03b1 were not altered in Arf \u2212/\u2212 macrophages. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "In addition to the modulation of surface markers expression, M1 and M2 macrophages display different cytokines and chemokines gene expression profiles. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "In order to analyze whether ARF deficiency alters these profiles, we performed a microarray analysis of 84 genes coding for pro-inflammatory cytokines and their receptors. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "The full list of genes and fold changes are shown in Table S1. ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 53,
                    "end": 61,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table S1"
                }
            ]
        },
        {
            "text": "As depicted in Table 1, ARF appears to play a key role in regulating the basal expression of several genes related with M2 polarization. ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 15,
                    "end": 22,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table 1"
                }
            ]
        },
        {
            "text": "Thus, in the group of genes upregulated in Arf \u2212/\u2212 macrophages, we found Ccl12 and Ccl17, two chemokines related to the M2 phenotype. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "In contrast, the expression of M1-related chemokines (Ccl2 and Cxcl10) was reduced. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "Microarray data were validated by quantitative PCR (Fig. 1C). ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 51,
                    "end": 60,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "(Fig. 1C)"
                }
            ]
        },
        {
            "text": "These results suggest that ARF deficiency might modulate macrophage differentiation toward a M2-like phenotype.",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "Impaired M1 polarization in ARF-deficient macrophages. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "One of the characteristics of M2-polarized cells is their ability to wane the inflammatory/immune response by inhibiting M1 macrophage-mediated functions. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "M1 macrophages are mainly induced by IFN\u03b3 or upon stimulation with bacterial products such as LPS. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "To investigate whether ARF deficiency contributes to the downregulation of M1-mediated inflammatory activities, we examined the levels of classical inflammatory mediators such as NO and prostaglandin E 2 (PGE 2 ). ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "Peritoneal macrophages from WT and Arf \u2212/\u2212 mice were stimulated with LPS or IFN\u03b3. ",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "As expected, the stimulation of WT macrophages with LPS generated high NO and PGE 2 levels, whereas a deficient response was observed in the absence of Arf ( Fig. 2A and B). ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 158,
                    "end": 172,
                    "type": "figure",
                    "text": "Fig. 2A and B)"
                }
            ]
        },
        {
            "text": "Accordingly, iNOS and COX-2 expression was upregulated in WT cells responding to LPS and IFN\u03b3, as compared with Arf \u2212/\u2212 macrophages ( Fig. 2C and D). ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 134,
                    "end": 148,
                    "type": "figure",
                    "text": "Fig. 2C and D)"
                }
            ]
        },
        {
            "text": "Similar to LPS, IFN\u03b3 induced NO release and iNOS activation, and once again, Arf \u2212/\u2212 cells showed a significantly reduced response as compared with WT macrophages ( Fig. 2E-G). ",
            "section": "ARF deficiency promotes the expression of M2 markers.",
            "ref_spans": [
                {
                    "start": 165,
                    "end": 175,
                    "type": "figure",
                    "text": "Fig. 2E-G)"
                }
            ]
        },
        {
            "text": "treatment (Figs. 5D and E), suggesting a pro-tumoral function for these cells.",
            "section": "ARF deficiency promotes the expression of M2 markers."
        },
        {
            "text": "To obtain a more comprehensive understanding of the cytokine/chemokine repertoire induced by IL-4 in Arf \u2212/\u2212 macrophages, we performed a microarray-based gene expression analysis. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "After 6 h of stimulation, only 14 genes were upregulated (> 2-fold) in WT macrophages ( Fig. 6A; Table 3). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 95,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Fig. 6A"
                },
                {
                    "start": 97,
                    "end": 104,
                    "type": "table",
                    "ref_id": "tab_2",
                    "text": "Table 3"
                }
            ]
        },
        {
            "text": "The overexpressed genes Ccl24, Ccl6, Ccr3, Ccr5 and Il6st were IL-4 specific since LPS treatment did not modify their expression levels (Fig. 3A). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 136,
                    "end": 145,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "(Fig. 3A)"
                }
            ]
        },
        {
            "text": "In addition, we also found some chemokines and receptors (Ccl11, Ccl22, Ccl5, and CCr3) highly expressed in IL-4 stimulated Arf \u2212/\u2212 macrophages as compared with WT cells. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "These results were validated by quantitative PCR analysis activity using an urea-based assay was observed in Arf \u2212/\u2212 macrophages as compared with WT cells (Fig. 4F).",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 155,
                    "end": 164,
                    "type": "figure",
                    "text": "(Fig. 4F)"
                }
            ]
        },
        {
            "text": "In agreement with the anti-inflammatory activity of M2 macrophages, the expression of IL-10 was considerably higher in Arf \u2212/\u2212 macrophages (Fig. 5A). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 139,
                    "end": 148,
                    "type": "figure",
                    "text": "(Fig. 5A)"
                }
            ]
        },
        {
            "text": "The differential expression of IL-10 in both types of macrophages was confirmed by measuring IL-10 levels in the supernatant (Fig. 5B). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 134,
                    "type": "figure",
                    "text": "(Fig. 5B)"
                }
            ]
        },
        {
            "text": "Moreover, we observed a higher expression of typical M2-surface markers (i.e., Fizz-1, Ym1 and MMR) in Arf \u2212/\u2212 macrophages responding to IL-4, as compared with their WT counterparts (Fig. 5C).",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 182,
                    "end": 191,
                    "type": "figure",
                    "text": "(Fig. 5C)"
                }
            ]
        },
        {
            "text": "In most tumor types, TAMs resemble alternatively activated macrophages in several aspects, including the release of proangiogenic factors. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "We observed that Arf \u2212/\u2212 macrophages significantly increased VEGF and MMP-9 expression after IL-4 Figure 2. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 98,
                    "end": 106,
                    "type": "figure",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "attenuated inflammatory response of aRF deficient macrophages to classical activation. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(A) peritoneal WT and aRF-deficient macrophages were stimulated with 200 ng/mL lipopolysaccharide (Lps) for 24 h and NO release was determined by the Griess reaction. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(B) pGe 2 levels were assessed by eLIsa in cells treated as in (A). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(C) peritoneal macrophages from WT and aRF-deficient mice were activated for 6 h with 200 ng/mL Lps and expression of iNOs and cOX-2 was evaluated by quantitative pcR. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(D) protein levels of iNOs and cOX-2 were evaluated by immunoblotting after stimulation of peritoneal macrophages with 200 ng/mL Lps for the indicated time. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Band intensities were quantified by densitometry, normalized to \u03b2-actin levels and represented as means \u00b1 sD of the fold change from control condition (n = 3). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(E) NO release of peritoneal macrophages from WT and arf \u2212/\u2212 mice after stimulation for 24 h with 50 ng/mL interferon \u03b3 (IFN\u03b3). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(F) iNOs induction was examined by quantitative pcR in WT and arf \u2212/\u2212 cells after treatment with 50 ng/mL IFN\u03b3 for 6 h. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(G) protein levels of iNOs were evaluated by immunoblotting after stimulation of peritoneal macrophages with 50 ng/mL IFN\u03b3 for 24 h. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Results were obtained from three independent experiments performed in triplicate and data are reported as means \u00b1 sD *p < 0.05, **p < 0.01 and ***p < 0.001 as compared with the same condition in WT macrophages. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "(D and G) are representative of one out of three independent experiments. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "state of TAMs. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "We demonstrate that, in the absence of ARF, macrophages have an impaired ability to develop pro-inflammatory properties, rather showing anti-inflammatory characteristics. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Arf \u2212/\u2212 macrophages expressed higher levels of IL-10, Fizz-1, Ym1, and increased arginase activity and lower levels of IL-12, TNF\u03b1, IFN\u03b3, PGE 2 and NO. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Moreover, Arf \u2212/\u2212 macrophages showed the upregulation of important pro-angiogenic factors (VEGF and MMP-9), which might contribute to tumor progression. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "These findings highlight the importance of ARF in the regulation of macrophage activation.",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "The tumor suppressor ARF is among the genes most frequently mutated in human cancer. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "9 Loss of ARF gene expression can abrogate immunosurveillance mechanisms and increase the susceptibility to cancer. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "9"
                }
            ]
        },
        {
            "text": "Indeed, mice lacking p19ARF are highly prone to tumor development 10,11 and deletion of ARF has been described in a variety of malignancies, including glioblastoma, melanoma, pancreatic adenocarcinoma, and non-small cell lung cancer. ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 66,
                    "end": 69,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "10,"
                },
                {
                    "start": 69,
                    "end": 71,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "11"
                }
            ]
        },
        {
            "text": "Interestingly, M2-polarized TAMs have been associated with poor prognosis and progression in many of these malignancies.",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Based on these premises and on our previous results showing impairment in the pro-inflammatory activation of ( Fig. 6B). ",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages.",
            "ref_spans": [
                {
                    "start": 111,
                    "end": 119,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Fig. 6B)"
                }
            ]
        },
        {
            "text": "Altogether, these data suggest that ARF deficiency promotes an enhanced response to inducers of the M2 polarization program, promoting a chemokine/cytokine pattern that may be viewed as that of a \"hyper-M2\" phenotype.",
            "section": "Cytokine and chemokine expression profiles in IL-4-treated macrophages."
        },
        {
            "text": "Macrophages are dynamic cells that might modify their functional profiles in response to the microenvironment. ",
            "section": "Discussion"
        },
        {
            "text": "Moreover, macrophages are increasingly recognized as pivotal regulators of tumorigenesis. ",
            "section": "Discussion"
        },
        {
            "text": "Accumulating evidence suggests that macrophages that infiltrate tumors acquire a phenotype of alternative activation (M2), exerting immunosuppressive functions through the release of anti-inflammatory cytokines and facilitating the progression of tumors via the production of proangiogenic factors. ",
            "section": "Discussion"
        },
        {
            "text": "1 Previously, we have described that the tumor suppressor ARF is an important mediator of the inflammatory response and of macrophage activation. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "1"
                }
            ]
        },
        {
            "text": "7 In the current study, we investigated whether ARF deficiency promotes macrophage differentiation toward a phenotype that resembles the alternatively-activated Arf \u2212/\u2212 macrophages. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "7"
                }
            ]
        },
        {
            "text": "In primary macrophages stimulated with LPS or IFN\u03b3, these included genes coding for pro-inflammatory cytokines (TNF\u03b1, IL-1\u03b2), chemokines (Cxcl10, Cxcl1, Ccl4) and inflammatory mediators (iNOS/PGE 2 ). ",
            "section": "Discussion"
        },
        {
            "text": "Accordingly, the absence of Arf is known to reduce the susceptibility of mice to septic shock. ",
            "section": "Discussion"
        },
        {
            "text": "7 Although mechanisms involved in this inhibitory effect have not been explored in this study, a decrease in NF\u03baB and MAPK activation has been described in Arf \u2212/\u2212 macrophages responding to LPS. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "7"
                }
            ]
        },
        {
            "text": "7 Similarly, inhibited degradation of I\u03baB has been observed in ARF-deficient macrophages stimulated with the vesicular stomatis virus. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "7"
                }
            ]
        },
        {
            "text": "12 Interestingly, the nuclear translocation of the p65/p50 heterodimers mainly associated with classical NF\u03baB activation was also inhibited in macrophages from Arf \u2212/\u2212 mice responding to LPS stimulation, 7 whereas massive accumulation of the p50 homodimer was observed (unpublished results), supporting the idea that ARF deficiency favors M2-driven inflammatory reactions.",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "12"
                },
                {
                    "start": 204,
                    "end": 205,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "7"
                }
            ]
        },
        {
            "text": "In addition to the downregulation of pro-inflammatory mediators, typical hallmarks of the anti-inflammatory M2 phenotype were increased in both resting and IL-4-treated Arf \u2212/\u2212 macrophages, including Arg-1, Fizz-1 and Ym1. ",
            "section": "Discussion"
        },
        {
            "text": "In mice, M2 macrophages are characterized by an alternative metabolism of l-arginine, mainly catalyzed by Arg-1. ",
            "section": "Discussion"
        },
        {
            "text": "Arg-1 is a cytosolic enzyme expressed at high levels in M2 macrophages that hydrolyzes Arf \u2212/\u2212 macrophages, we hypothesized that ARF might modulate the M1/M2 polarization and functional plasticity of macrophages. ",
            "section": "Discussion"
        },
        {
            "text": "We have demonstrated that genes involved in M1 polarization, antimicrobial and antitumoral responses are downregulated in  studies showing a direct correlation between the M2 phenotype and a elevated expression of these genes. ",
            "section": "Discussion"
        },
        {
            "text": "5 Interestingly, Fizz-1 and Ym1 have been shown to exert angiogenic effects, stimulating actin and collagen expression, and have been implicated in tissue repair. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "5"
                }
            ]
        },
        {
            "text": "18,19 M2 macrophages and TAMs play an important role in tumor angiogenesis, as they produce critical factors including VEGF and MMP-9. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "18,"
                },
                {
                    "start": 3,
                    "end": 5,
                    "type": "bibr",
                    "ref_id": "b34",
                    "text": "19"
                }
            ]
        },
        {
            "text": "20 Our results demonstrate that Arf \u2212/\u2212 macrophages produce high levels of these angiogenesis-associated molecules, supporting the idea of that these cells exert tumor-supporting functions. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "20"
                }
            ]
        },
        {
            "text": "Consistent with this notion, recent studies have demonstrated a role for ARF in suppressing tumor angiogenesis by arginine to urea and ornithine. ",
            "section": "Discussion"
        },
        {
            "text": "8 Elevated Arg-1 expression might promote tumor growth via several mechanisms, including the downregulation of NO-mediated tumor cytotoxicity, 13 increased tumor proliferation (due to alterations in polyamine and proline synthesis), and enhancements of the capacity of myeloidderived suppressor cells to inhibit T cell proliferation. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "8"
                },
                {
                    "start": 143,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b18",
                    "text": "13"
                }
            ]
        },
        {
            "text": "14,15 Indeed, increased expression of Arg-1 in TAMs has been described in 3LL murine lung carcinoma, 14 in human papillomavirus E6/ E7-expressing murine tumors 16 and in CD11b + /CD14 \u2212 myeloid cells from renal carcinoma patients. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "14,"
                },
                {
                    "start": 3,
                    "end": 5,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "15"
                },
                {
                    "start": 101,
                    "end": 103,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "14"
                },
                {
                    "start": 160,
                    "end": 162,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "16"
                }
            ]
        },
        {
            "text": "17 Together with Arg-1 overexpression, an increase in Fizz-1 and Ym1 levels was observed in Arf \u2212/\u2212 macrophages. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b31",
                    "text": "17"
                }
            ]
        },
        {
            "text": "These data are in agreement with other Figure 4. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 39,
                    "end": 47,
                    "type": "figure",
                    "text": "Figure 4"
                }
            ]
        },
        {
            "text": "exacerbated activation of arf \u2212/\u2212 macrophages in response to IL-4. ",
            "section": "Discussion"
        },
        {
            "text": "(A) WT and Arf \u2212/\u2212 macrophages were treated with 200 ng/mL lipopolysaccharide (Lps), 50 ng/mL interferon \u03b3 (IFN\u03b3), 20 ng/mL IL-4 and 20 ng/mL IL-13 for 24 h and NO release was determined by the Griess reaction. ",
            "section": "Discussion"
        },
        {
            "text": "(B) peritoneal macrophages from WT and aRF-deficient mice were treated with 200 ng/mL Lps and 20 ng/mL IL-4 and expression of iNOs and cOX-2 was evaluated by quantitative pcR. ",
            "section": "Discussion"
        },
        {
            "text": "(C) protein levels of iNOs and cOX-2 were evaluated by immunoblotting after stimulation of peritoneal macrophages as in (A). ",
            "section": "Discussion"
        },
        {
            "text": "(D) arg-1 expression was examined by quantitative pcR in WT and arf \u2212/\u2212 cells after stimulation with 200 ng/mL Lps and 20 ng/mL IL-4 for 6 h. ",
            "section": "Discussion"
        },
        {
            "text": "(E) protein levels of arg-1 were evaluated by immunoblotting after stimulation of peritoneal macrophages with 20 ng/mL IL-4 for 24 h. ",
            "section": "Discussion"
        },
        {
            "text": "(F) WT and arf \u2212/\u2212 macrophages were treated with 20 ng/mL IL-4 for 24 h and production of urea was determined. ",
            "section": "Discussion"
        },
        {
            "text": "Results were obtained from three independent experiments performed in triplicate and data are reported as means \u00b1 sD *p < 0.05, and **p < 0.01, as compared with WT mice. ",
            "section": "Discussion"
        },
        {
            "text": "(B and E) are representative of one out of three independent experiments. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 9,
                    "type": "figure",
                    "text": "(B and E)"
                }
            ]
        },
        {
            "text": "(C and E) band intensities were quantified by densitometry, normalized to \u03b2-actin levels and represented as means \u00b1 sD of the fold change from control condition (n = 3). ",
            "section": "Discussion"
        },
        {
            "text": "might result in the recruitment of Tregs, Th2 cells, eosinophils and basophils and in the amplification of Th2 responses. ",
            "section": "Discussion"
        },
        {
            "text": "Moreover, Arf \u2212/\u2212 macrophages showed a significant increase in IL-10 levels, which contribute to the maintenance of an immunosuppressive environment. ",
            "section": "Discussion"
        },
        {
            "text": "Taken together, these findings indicate that resting Arf \u2212/\u2212 macrophages acquire an M2-like phenotype. ",
            "section": "Discussion"
        },
        {
            "text": "Moreover, Arf \u2212/\u2212 macrophages exhibit a higher expression of M2-associated immunomodulatory genes in response to alternative activation stimuli.",
            "section": "Discussion"
        },
        {
            "text": "In summary, we propose that ARF-deficient macrophages can contribute to the establishment of a tolerogenic microenviroment, faciliting tumor progression as a result of (1) immunosuppression, through the production of anti-inflammatory IL-10 and the secretion of Ccl22 and Ccl2, which attract Tregs, (2) stimulation of angiogenesis, through the upregulation of VEGF and MMP-9, and (3) induction of extracellular matrix remodeling, through the production of MMP-9, Fizz-1 and Ym1 (Fig. 7). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 478,
                    "end": 486,
                    "type": "figure",
                    "text": "(Fig. 7)"
                }
            ]
        },
        {
            "text": "Further experiments analyzing the phenotype of macrophages that regulating the expression of VEGF 21 and the activity of its transactivator hypoxia-inducible factor-1 (HIF-1). ",
            "section": "Discussion"
        },
        {
            "text": "22 Notably, ARF has also been described to inhibit angiogenesis by upregulating the expression of TIMP3, an inhibitor of MMPs activity. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "22"
                }
            ]
        },
        {
            "text": "23 Another important feature that discriminates M1 and M2 macrophages is their cytokine and chemokine repertoire. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "23"
                }
            ]
        },
        {
            "text": "M1 macrophages produce inflammatory chemokines such as Cxcl9 and Cxcl10, which induce the recruitment of Th1 cells, whereas M2 polarization is accompanied by the production of immunosuppressive cytokines (e.g., IL-10 and TGF\u03b2) and chemokines such as Ccl17, Ccl22 and Ccl24 1,4,24 that favor the recruitment of immunosuppressive cells such like regulatory T cells (Tregs). ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 273,
                    "end": 275,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "1,"
                },
                {
                    "start": 275,
                    "end": 277,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "4,"
                },
                {
                    "start": 277,
                    "end": 279,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "24"
                }
            ]
        },
        {
            "text": "Analysis of the cytokine and chemokine profile in Arf \u2212/\u2212 macrophages showed a clear correlation with M2 phenotype. ",
            "section": "Discussion"
        },
        {
            "text": "Notably, chemokines typically involved in lymphocyte recruitment, such as Ccl5 and the Ccr4 ligands Ccl17 and Ccl22 were consistently higher after the administration of IL-4 treatment in Arf \u2212/\u2212 , but not in WT, macrophages. ",
            "section": "Discussion"
        },
        {
            "text": "Thus, the release of these chemokines Figure 5. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 38,
                    "end": 46,
                    "type": "figure",
                    "text": "Figure 5"
                }
            ]
        },
        {
            "text": "M2 phenotype markers and pro-angiogenic factors are increased in IL-4-treated arf \u2212/\u2212 macrophages. ",
            "section": "Discussion"
        },
        {
            "text": "(A) peritoneal macrophages from WT and aRF-deficient mice were treated with 20 ng/mL IL-4 for 6 h, and the expression of IL-10 was evaluated by quantitative pcR. ",
            "section": "Discussion"
        },
        {
            "text": "(B) IL-10 levels were measured by eLIsa in supernatants of WT and arf \u2212/\u2212 macrophages treated for 24 h with 20 ng/mL IL-4. ",
            "section": "Discussion"
        },
        {
            "text": "(C) WT and arf \u2212/\u2212 macrophages were treated as in a and Fizz-1, Ym1 and MMR expression was examined by quantitative pcR. ",
            "section": "Discussion"
        },
        {
            "text": "(D) VeGF and MMp-9 expression was examined by quantitative pcR in WT and arf \u2212/\u2212 cells upon stimulation with 20 ng/mL IL-4 for 6 h. ",
            "section": "Discussion"
        },
        {
            "text": "(E) VeGF levels were determined by eLIsa after stimulation of WT and arf \u2212/\u2212 cells with 20 ng/mL IL-4 for 24 h. ",
            "section": "Discussion"
        },
        {
            "text": "Results were obtained from three independent experiments performed in triplicate and data are reported as means \u00b1 sD *p < 0.05, **p < 0.01 and ***p < 0.001, as compared with untreated WT cells, and a p < 0.05, b p < 0.01, as compared with WT cells.",
            "section": "Discussion"
        },
        {
            "text": "infiltrate tumors in Arf \u2212/\u2212 mice might provide further insights into macrophage plasticity, thus facilitating the development of new therapeutic strategies.",
            "section": "Discussion"
        },
        {
            "text": "Materials and reagents. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Ultrapure 0111:B4 lipopolysaccharide (LPS) from Escherichia coli was purchased from InvivoGen. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Murine IFN\u03b3, IL-4 and IL-13 were provided by Peprotech. ",
            "section": "Materials and Methods"
        },
        {
            "text": "The mouse RT 2 Profiler PCR Inflammatory Cytokines and Receptors array, the RT 2 First Strand kit and SYBR Green/Fluorescein qPCR master mix were from SABiosciences. ",
            "section": "Materials and Methods"
        },
        {
            "text": "TRIzol reagent was from Invitrogen. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Difco thioglycollate broth was from Becton-Dickinson. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Anti-iNOS and anti-COX-2 antibodies were from Abcam, anti-arginase-1 and anti-\u03b2-actin antibodies were from Santa Cruz Biotechnology. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Immunoblotting reagents (polyvinylidene difluoride membranes and ECL kit) were from GE Healthcare. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Culture media were from Lonza. ",
            "section": "Materials and Methods"
        },
        {
            "text": "l-arginine, urea and 1-phenyl-1,2-propanedione-2-oxime were from Sigma.",
            "section": "Materials and Methods"
        },
        {
            "text": "Animals. ",
            "section": "Materials and Methods"
        },
        {
            "text": "All procedures involving animals were performed in accordance with European Union guidelines and the Declaration of Helsinki principles for the handling and use of laboratory animals. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Studies were performed on 12-week-old Arf +/+ (WT), and Arf \u2212/\u2212 C57BL/6J mice.",
            "section": "Materials and Methods"
        },
        {
            "text": "Preparation of elicited peritoneal macrophages. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Peritoneal macrophages were elicited by intraperitoneal injection of 2.5 mL 3% thioglycollate in distilled water and were prepared as previously described. ",
            "section": "Materials and Methods"
        },
        {
            "text": "25 Cells were seeded at 1 \u00d7 10 6 /cm 2 in RPMI medium containing 10% FBS. ",
            "section": "Materials and Methods",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b30",
                    "text": "25"
                }
            ]
        },
        {
            "text": "Non-adherent cells were removed 2 h after seeding by extensive washing with medium.",
            "section": "Materials and Methods"
        },
        {
            "text": "Determination of NO synthesis. ",
            "section": "Materials and Methods"
        },
        {
            "text": "NO was measured by the Griess reaction as previously described. ",
            "section": "Materials and Methods"
        },
        {
            "text": "26 Briefly, NO release was determined spectrophotometrically as the accumulation of nitrite in the medium. ",
            "section": "Materials and Methods",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "26"
                }
            ]
        },
        {
            "text": "Absorbance at 548 nm was compared with standard NaNO 2 solutions.",
            "section": "Materials and Methods"
        },
        {
            "text": "Assay of PGE 2 , VEGF and IL-10 release. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Supernatants from WT and Arf \u2212/\u2212 macrophages were tested for the presence of PGE 2 VEGF, and cytokines using commercially available ELISA following the protocols supplied by the manufacturers (R&D Systems).",
            "section": "Materials and Methods"
        },
        {
            "text": "Arginase activity measurement. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Arginase activity was assessed in cell lysates indirectly by measuring urea concentration generated by the arginase-dependent hydrolysis of l-arginine. ",
            "section": "Materials and Methods"
        },
        {
            "text": "27 Briefly, cells were lysed with 20 mM Tris (pH 7.5), 150 mM NaCl, 2 mM EDTA, and 0.1% Triton X-100-containing protease inhibitor mixture (Sigma) for 30 min at room temperature. ",
            "section": "Materials and Methods",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "27"
                }
            ]
        },
        {
            "text": "Standards were prepared by serially diluting a stock of urea in 50 mM TRIS-HCl Figure 7. ",
            "section": "Materials and Methods",
            "ref_spans": [
                {
                    "start": 79,
                    "end": 87,
                    "type": "figure",
                    "text": "Figure 7"
                }
            ]
        },
        {
            "text": "a simplified view for M2-type activation in aRF-deficient macrophages. ",
            "section": "Materials and Methods"
        },
        {
            "text": "In WT macrophages, a balance between the M1 and M2 phenotype is established, depending on the initiating stimuli. ",
            "section": "Materials and Methods"
        },
        {
            "text": "however, aRF-deficient macrophages establish an immunosuppressive and tolerant microenvironment upon the impairment of M1 signals, secretion of the M2 chemokines ccl17 and ccl22 as well as of the anti-inflammatory cytokine IL-10, and stimulation of angiogenesis through expression of VeGF and MMp-9. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Green and red arrows depict genes that are downregulated and upregulated, respectively, in aRF-deficient macrophages as compared to their WT counterparts.",
            "section": "Materials and Methods"
        },
        {
            "text": "Tubes were then incubated for 10 min at 55\u00b0C for activation. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Next, arginine hydrolysis was conducted by incubating 50 \u03bcL of the lysates and standards with 50 \u03bcL of 0.5 M l-arginine at 37\u00b0C for 75 min, followed by the addition of 400 \u03bcL stopping solution (H 2 SO 4 /H 3 PO 4 /H 2 O = 1/3/7, v/v/v). ",
            "section": "Materials and Methods"
        },
        {
            "text": "To measure the amount of urea in each tube, 50 \u03bcL of 9% 1-phenyl-1,2-propanedione-2-oxime (Sigma) in 100% ethanol was added to each sample and standard, and tubes were incubated at 100\u00b0C for 60 min. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Tubes were placed in the dark at 25\u00b0C for 30 min. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Samples and standards (100 \u03bcL/well) were transferred in triplicate to a 96-well plate, and optical density was read at 540 nm with 690 nm correction. ",
            "section": "Materials and Methods"
        },
        {
            "text": "The concentration of samples was determined from the standard curve and converted to arginase units using the following formula: urea produced (\u03bcg/mL) / total protein (\u03bcg/mL).",
            "section": "Materials and Methods"
        },
        {
            "text": "Total extracts and immunoblotting. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Cells were lysed at 4\u00b0C with 0.2 mL buffer A (0.5% Chaps, 10mM Tris pH 7.5, 1mM Cl 2 Mg, 1mM EGTA, 10% Glycerol, 5 mM \u03b2) and protease inhibitor cocktail (Sigma). ",
            "section": "Materials and Methods"
        },
        {
            "text": "Protein content was assayed with the Bio-Rad protein reagent. ",
            "section": "Materials and Methods"
        },
        {
            "text": "All cell fractionation steps were performed at 4\u00b0C. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Protein extracts were subjected to SDS-PAGE (10-15% gels) and blotted onto polyvinylidene difluoride membranes, which were incubated antibodies specific for Arg-1, iNOS, COX-2 and \u03b2-actin. ",
            "section": "Materials and Methods"
        },
        {
            "text": "After incubation with HRPconjugated secondary antibody, protein bands were revealed with an enhanced chemiluminescence kit (GE Healthcare). ",
            "section": "Materials and Methods"
        },
        {
            "text": "\u03b2-actin was used as a loading control. ",
            "section": "Materials and Methods"
        },
        {
            "text": "After treatment with 100 mM \u03b2-mercaptoethanol, 2% SDS in TBS and heating at 60\u00b0C for 30 min, blots were sequentially probed with other antibodies.",
            "section": "Materials and Methods"
        },
        {
            "text": "RNA isolation and quantitative PCR. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Total RNA was isolated from cells with Trizol reagent (Invitrogen). ",
            "section": "Materials and Methods"
        },
        {
            "text": "Quantitative PCR (SYBR Green) analysis was performed with an ABI 7500 Fast sequence analyzer as previously described. ",
            "section": "Materials and Methods"
        },
        {
            "text": "28 Each sample was run in duplicate, and all samples were analyzed in parallel for the expression of the housekeeping gene 36B4 (acidic ribosomal phosphoprotein P0), which was used as an endogenous control for normalization of the expression level of target genes. ",
            "section": "Materials and Methods",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "28"
                }
            ]
        },
        {
            "text": "Fold induction was determined from mean replicate values. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Primer sequences are available on request.",
            "section": "Materials and Methods"
        },
        {
            "text": "Gene expression profile. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Expression of inflammatory genes was evaluated with the mouse RT 2 Profiler PCR Inflammatory Cytokines and Receptors Array (SABiosciences). ",
            "section": "Materials and Methods"
        },
        {
            "text": "Briefly, 2 \u03bcg of RNA were used for cDNA synthesis with RT 2 First Standard kit (SABiosciences). ",
            "section": "Materials and Methods"
        },
        {
            "text": "The RT 2 Profiler array was probed according to the manufacturer's protocol, using the Profiler PCR Array System and SYBR Green/Fluorescein qPCR master mix (SABiosciences) in an ABI 7500 Fast sequence analyzer (Applied Biosystems). ",
            "section": "Materials and Methods"
        },
        {
            "text": "Gene expression was compared with the web-based software package for the PCR Array System (http://www.superarray.com/ pcr/arrayanalysis.php), which automatically performs all \u0394\u0394Ct based fold-change calculations from the specific uploaded raw threshold cycle data.",
            "section": "Materials and Methods"
        },
        {
            "text": "Statistical analysis. ",
            "section": "Materials and Methods"
        },
        {
            "text": "The data presented are shown as means \u00b1 SD of three or five independent experiments. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Statistical significance was estimated by Student's t test for unpaired observations and one-or two-way ANOVA, followed by Bonferroni's, Tukey's, or Dunnett's post-hoc comparisons. ",
            "section": "Materials and Methods"
        },
        {
            "text": "Differences were considered significant at when p values were < 0.05. ",
            "section": "Materials and Methods"
        },
        {
            "text": "All statistical analyses were conducted using GraphPad Prism 5.0 (GraphPad Software). ",
            "section": "Materials and Methods",
            "entity_spans": [
                {
                    "start": 46,
                    "end": 60,
                    "type": "software",
                    "rawForm": "GraphPad Prism",
                    "resp": "#annotator26",
                    "used": true,
                    "id": "c2a316b42a-software-1",
                    "cert": "1.0"
                },
                {
                    "start": 61,
                    "end": 64,
                    "type": "version",
                    "rawForm": "5.0",
                    "resp": "#annotator26",
                    "id": "#c2a316b42a-software-1"
                },
                {
                    "start": 66,
                    "end": 83,
                    "type": "publisher",
                    "rawForm": "GraphPad Software",
                    "resp": "#curator",
                    "id": "#c2a316b42a-software-1"
                }
            ]
        },
        {
            "text": "For immunoblots, a linear correlation was observed between increasing amounts of input protein and signal intensity.",
            "section": "Materials and Methods"
        },
        {
            "text": "No potential conflicts of interest were disclosed.",
            "section": "Disclosure of Potential Conflicts of Interest"
        },
        {
            "text": "This study was supported by grant PI11.0036 from the FIS and MPY 1410/09 from ISCIII to S.H.",
            "section": "Acknowledgments"
        },
        {
            "text": "Supplemental materials may be found here: w w w.landesbioscience.com /journals /oncoimmunolog y/ article/21207",
            "section": "Supplemental Materials"
        }
    ]
}